CEO Transition
Open PDF
| Stock | Painchek Ltd (PCK.ASX) |
|---|---|
| Release Time | 6 Jul 2026, 4:33 p.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Painchek Ltd Announces CEO Transition
Key Points
- Philip Daffas has stepped down as CEO and Managing Director
- Andy Hoggan appointed as Interim CEO
- Transition supports FY2027 strategy and US market development
Full Summary
PainChek Ltd, developer of the world's first AI-powered pain assessment and monitoring application, announced that Philip Daffas will cease to serve as CEO and Managing Director effective immediately. This transition supports PainChek's Financial Year 2027 strategy following FDA De Novo clearance. The Board thanks Philip for his ten years of leadership and wishes him well in his next endeavors. Andy Hoggan, currently COO, will act as Interim CEO during the transition period. The Board expects to announce a new CEO in due course.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In